StockData
Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc. (SANA) stock

SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$1.85−0.03 (-1.60%)

Close on Nov 18, 2026Market cap $553.82MP/E –Yield –

Sana Biotechnology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Sana Biotechnology's operating cash flow for the twelve months ending Jun 30, 2026 was -$132.24M. For fiscal 2025 it was -$143.83M. The highest annual figure on record is -$85.52M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$143.83M–
FY2024Dec 31, 2024-$223.15M–
FY2023Dec 31, 2023-$253.58M–
FY2022Dec 31, 2022-$290.05M–
FY2021Dec 31, 2021-$251.05M–
FY2020Dec 31, 2020-$137.98M–
FY2019Dec 31, 2019-$85.52M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$32.79M–
Q1 FY2026Mar 31, 2026-$37.38M–
Q4 FY2025Dec 31, 2025-$32.64M–
Q3 FY2025Sep 30, 2025-$29.43M–
Q2 FY2025Jun 30, 2025-$33.10M–
Q1 FY2025Mar 31, 2025-$48.66M–
Q4 FY2024Dec 31, 2024-$47.16M–
Q3 FY2024Sep 30, 2024-$51.82M–
Q2 FY2024Jun 30, 2024-$58.54M–
Q1 FY2024Mar 31, 2024-$65.63M–
Q4 FY2023Dec 31, 2023-$51.96M–
Q3 FY2023Sep 30, 2023-$63.55M–
Q2 FY2023Jun 30, 2023-$58.80M–
Q1 FY2023Mar 31, 2023-$79.27M–
Q4 FY2022Dec 31, 2022-$76.07M–
Q3 FY2022Sep 30, 2022-$64.80M–
Q2 FY2022Jun 30, 2022-$71.48M–
Q1 FY2022Mar 31, 2022-$77.71M–
Q4 FY2021Dec 31, 2021-$110.10M–
Q3 FY2021Sep 30, 2021-$50.49M–
Q2 FY2021Jun 30, 2021-$40.56M–
Q1 FY2021Mar 31, 2021-$49.91M–
Q4 FY2020Dec 31, 2020-$37.56M–
Q3 FY2020Sep 30, 2020-$37.51M–
Q2 FY2020Jun 30, 2020-$33.37M–
Q1 FY2020Mar 31, 2020-$29.55M–

More Sana Biotechnology figures

See a number that looks wrong?